Hemp Stocks

793 posts / 0 new
Letzter Beitrag
Lorenz
Bild des Benutzers Lorenz
Offline
Zuletzt online: 09.11.2018
Mitglied seit: 16.04.2010
Kommentare: 1'405
ACB und CGC

Hier kommt heute scon wieder Erfreuliches:

Quelle:

http://marijuanastocks.com/acbff-to-acquire-cannabis-science-leader-anandia-laboratories-inc/

Aurora Cannabis to Acquire Cannabis Science Leader Anandia Laboratories Inc.

Aurora Cannabis Inc. (“Aurora” or the “Company”) (ACB.TO) (ACBFF) ( Frankfurt : 21P; WKN: A1C4WM) and Anandia Laboratories Inc. (“Anandia“) announced today that they have signed a binding term sheet whereby Aurora intends to acquire all of the issued and outstanding common shares of privately-held Anandia in an all share transaction valued at approximately $115 million on a fully diluted basis (the “Transaction”).

Led by CEO and co-founder Jonathan Page , PhD, one of the industry’s most widely recognized cannabis experts, Anandia is considered the industry leader in science, genetics, and independent cannabis product testing. Dr. Page was the first scientist to sequence the cannabis genome and provide deep insights into the biosynthesis of cannabinoids and the interplay between cannabinoids and terpenes.

Anandia’s COO and co-founder, John Coleman , PhD, brings over 20 years of experience in drug research and commercialization as a natural product chemist. He previously worked in the biotech industry, most recently leading the team identifying new drug targets for the federally funded Centre for Drug Research and Development.

Anandia’s intellectual property (“IP”) includes the exclusive rights to a number of key genes in the cannabinoid pathway, as well as patents pending for genetic markers. The strength of Anandia’s expert staff, proprietary assets and know-how will provide Aurora with a very significant advantage in developing new cannabis cultivars. For instance, genome-based variety development and technological fortification can tailor metabolite (cannabinoid and terpene) profiles, improve disease resistance, enhance crop yield and optimize flowering time, and can be employed to develop specialized cultivars for oil production.

In advance of the forthcoming legalization of the adult use market and the significant associated growth, Anandia intends to expand its R&D, product testing, and product development facilities to meet both domestic and international demand, including the development of:

  • A 12,700 sq. ft. corporate head office, testing lab, R&D and tissue culture facility in Vancouver, British Columbia . This existing laboratory is undergoing security upgrades, with operations planned to coincide with legalization.
  • A unique, 22,500 sq. ft., Aurora Larssen Projects Inc. (“ALP’s”) designed and constructed, Cannabis Innovation Centre, focused on cannabis breeding and genetics. This purpose-built greenhouse with an associated 10,000 sq. ft. laboratory building in Comox, BC is currently under construction and is located five minutes from a major airport, and has the option to expand to 100,000+ sq. ft. The project is on track with development permitting in-place, and construction planned for summer/fall 2018.

Anandia follows a three-pronged approach to creating value for its clients licensed under Canada’s Access to Cannabis for Medical Purposes Regulations (“ACMPR”) and intends to continue to do so following completion of the Transaction:

  • Independent Third-Party Analytical Testing: which includes cannabinoids, terpenes and contaminants (microorganisms, pesticides, heavy metals and others).
  • Genetics: plant breeding, tissue culture and strain archiving, as well as genomics-based technologies.
  • Product Development: development of cannabinoid preparations and formulations.

Combining with Aurora gives Anandia access to significant new market opportunities in Canada and internationally through Aurora’s global footprint. Furthermore, leveraging Aurora’s capabilities and capacity in facility development, the combination will accelerate the construction of Anandia’s testing and product development laboratory in Vancouver , and a unique, purpose-built cannabis breeding facility ahead of Canadian adult-use legalization,

Anandia’s Product Testing

Anandia’s cannabis testing services will remain operationally independent of Aurora. These services will remain intact and Anandia is committed to continuing to serve all clients, including Licensed Producers and patient-growers, and Anandia is committed to maintaining complete data confidentiality. Anandia will continue to build capacity to take on the increased sample volume arising from legalization, including expansion to its new testing facility in Vancouver .

Management Commentary

“This is a transformative acquisition that expands our science capabilities in the upstream segment of the seed-to-sale cannabis value chain, significantly boosting plant-based innovations in cultivation, enabling accelerated product development, and, ultimately, enhancing our margin profile going forward,” said Terry Booth , CEO of Aurora. “Anandia has a fantastic, complementary corporate culture and some of the best and brightest minds in the cannabis industry, including Dr. Jonathan Page , the first scientist to sequence the cannabis genome. By adding Dr. Page and the Anandia team to the existing Aurora and CanniMed research infrastructure, we are assembling a unique, world-class research group to capitalize on the many exciting opportunities the cannabis plant offers society.”

Dr. Jonathan Page , Anandia’s co-founder and CEO, added, “Anandia is already on its way to developing a world-leading library of cannabis genetics coupled with in-depth genomic analysis. We expect our breeding efforts to be accelerated through access to Aurora’s financial resources and scientific expertise, as well as through the addition of Aurora’s multiple cultivation sites. Anandia and Aurora are strong believers in research and science-based solutions. Joining forces with Aurora allows us to continue to provide best-in-class testing services to our customers, while rapidly advancing cannabis science for the benefit of patients, consumers and growers.”

Und von gestern noch dies:

http://marijuanastocks.com/aurora-cannabis-inc-acbff-signs-supply-agreement-with-ascent-industries/

 

Hier noch was von CGC (ich habe momentan grad keine, warte mal, wie das so kommt an der US-Börse)

Canopy to go ahead with pot trials to treat insomnia

2018-06-12 09:58 ET - News Release

 

Mr. Mark Zekulin reports

MEDICAL CANNABIS LEADERSHIP FROM CANOPY GROWTH AND SUBSIDIARY SPECTRUM CANNABIS

Canopy Growth Corp. has provided the following updates on its medical cannabis program and has reaffirmed its strong commitment to medical cannabis, the patients who depend on it and the health care professionals who prescribe it.

Historic clinical trial milestones

Marking a major milestone for medical cannabis in Canada, a phase IIb in-human clinical trial application was submitted by Canopy Health Innovations Inc. to evaluate the use of medical cannabis in the treatment of insomnia. Having received approval to proceed with these clinical trials in the form of a no objection letter (NOL) from Health Canada, Canopy Health will now proceed with these robust clinical trials, in collaboration with a leading Canadian research institution.

In light of the significant potential for cannabis in treating a range of medical conditions, this is the first in a planned series of trials to investigate and quantify the therapeutic effect of cannabis and cannabinoids across a selection of indications with significant unmet needs, working toward the ultimate goal of patented, insurance-eligible cannabinoid-based medicines.

World-class leadership for a global industry

As previously announced, starting in July, 2018, Dr. Mark Ware will commence his role as the company's chief medical officer. Under his leadership the company will continue to lead the global medical cannabis industry forward with a focus on research, product innovation and stakeholder education in the numerous regions where Spectrum Cannabis operates, including Latin America, Australia, Europe and North America.

Patients-first pricing mentality

Honouring the company's commitment to affordable medical cannabis and pricing predictability for patients, Canopy Growth is pleased to inform patients that, upon the passing of the Cannabis Act, the company will absorb the proposed excise tax on all Spectrum Cannabis products sold in Canada. Affordability is a key consideration for patients. It is important today to show leadership and reduce the price burden placed on customers, while the company works toward insurance eligibility for medical cannabis.

On top of this, all Spectrum Cannabis dried flower products will be priced at $8.50 per gram or less. If a registered customer is currently paying more for a Spectrum flower product this means new savings, and if they are paying less that price will remain the same. As always, Spectrum Cannabis products available on-line through the Tweed Main Street website are eligible for the company's industry-first compassionate pricing program that assists those on limited incomes afford their medicine.

"Using Canada's rich ecosystem of researchers and established cannabis stakeholders as a centre of expertise, Spectrum's global expansion is rooted in sophistication," said Mark Zekulin, president, Canopy Growth. "We are proudly a research- and patient-focused company that will continue to drive the cannabis innovation agenda forward around the world."

Here is to future growth.

About Canopy Growth Corp.

Canopy Growth is a world-leading diversified cannabis and hemp company, offering distinct brands and curated cannabis varieties in dried, oil and softgel capsule forms. From product and process innovation to market execution, Canopy Growth is driven by a passion for leadership and a commitment to building a world-class cannabis company one product, site and country at a time.

We seek Safe Harbor.

© 2018 Canjex Publishing Ltd. All rights reserved.

Und von gestern die News.

http://www.stockwatch.com/News/Item.aspx?bid=Z-C:WEED-2621823

 

Selector
Bild des Benutzers Selector
Offline
Zuletzt online: 31.10.2018
Mitglied seit: 06.06.2011
Kommentare: 678
ACB-News

Ja, hier geht was zurzeit:

Info heute:

Aurora Cannabis to acquire 8% of Choom Holdings

2018-06-13 08:02 ET - News Release

Mr. Terry Booth reports

AURORA CANNABIS TO BE LEAD INVESTOR IN CHOOM HOLDINGS PRIVATE PLACEMENT

Aurora Cannabis Inc. intends to complete a $7-million investment in Choom Holdings Inc., whereby Aurora will receive 9,859,155 common shares from Choom's treasury, priced at 71 cents per share, representing an 8-per-cent ownership interest.

Choom currently operates two late-stage applicants under the Access to Cannabis for Medical Purposes Regulations (ACMPR). Choom has agreements in place to acquire two additional late-stage applicant craft growers in British Columbia and Saskatchewan, including a facility in Sooke, B.C., anticipated to receive its cultivation licence from Health Canada in the third quarter of 2018.

The relationship between Aurora and Choom germinated through Aurora Pro, the platform through which the company delivers a variety of services to industry participants, including cultivation, genetics, regulatory consultancy and market development services. The Aurora Pro platform was developed by Aurora to interact with craft growers who are faced with potentially unreasonable entry barriers to the adult usage market in Canada.

Choom's strategy is to develop a carefully curated portfolio of high-grade cannabis strains with ideal characteristics for craft growing, targeting the premium segment of the adult consumer use market. Choom continues to develop a sophisticated brand, high-grade products and an elevated in-store customer experience. Images of the company's concept cannabis retail outlets can be found on-line.

To date, Choom has secured rights to 17 retail leases in highly defensible locations throughout Alberta. Applications to obtain a cannabis retail licence for these outlets have been submitted. Choom also has seven leases secured in B.C. and licences will be applied for upon commencement of the licensing program in B.C. Choom furthermore intends to play an important role in the Saskatchewan retail market and has a robust strategy in place to develop its presence in this market.

Management commentary

"Our investment in a consumer-focused brand with a strong retail strategy offers Aurora additional growth opportunities through supply, retail and distribution to the adult consumer use market, and provides a good example of the functioning of Aurora Pro," said Terry Booth, chief executive officer of Aurora. "Choom has established a well-developed brand, supported by deep roots within the British Columbia cannabis community and a passion for high-grade, handcrafted product. We're excited to strengthen our relationship with the team at Choom and help amplify their market reach as they continue to execute on their differentiated craft growing philosophy and their unique retail strategy."

Chris Bogart, president and CEO for Choom, added: "Teaming up with what we consider to be the most dynamic licensed producer with exceptional strength throughout the entire cannabis value chain, we believe, will prove to be a key growth accelerator for Choom. Both companies have a very strong focus on the entire customer experience, key in establishing exceptional brands. This investment by Aurora is a strong signal to our markets and our shareholders that Choom's strategy meets with the highest standards in the industry."

About Aurora Cannabis Inc.

Aurora's wholly owned subsidiary, Aurora Enterprises Inc., is a licensed producer of medical cannabis pursuant to Health Canada's Access to Cannabis for Medical Purposes Regulations (ACMPR). The company operates a 55,200-square-foot, state-of-the-art production facility in Mountain View county, Alberta, known as Aurora Mountain, and a second 40,000-square-foot high-technology production facility known as Aurora Vie in Pointe-Claire, Que., on Montreal's West Island. In January, 2018, Aurora's 800,000-square-foot flagship cultivation facility, Aurora Sky, located at the Edmonton International Airport, was licensed by Health Canada. Once at full capacity, Aurora Sky is expected to produce over 100,000 kilograms per annum of cannabis.

About Choom Holdings Inc.

Choom was created for and inspired by the Choom gang, a group of buddies in Honolulu during the 1970s who loved to smoke weed -- or as the locals called it, choom. Now, after four decades, Choom is bringing the spirit of Hawaii to Canada. Choom is focused on delivering an elevated customer experience through its curated retail environments, high-grade handcrafted cannabis supply and a diversity of brands for the Canadian recreational consumer.

We seek Safe Harbor.

© 2018 Canjex Publishing Ltd. All rights reserved.

 

Dann war da noch:

http://www.stockhouse.com/news/newswire/2018/06/12/micron-waste-to-deliver-cannabis-waste-digester-to-aurora

 

Emil
Bild des Benutzers Emil
Offline
Zuletzt online: 08.11.2018
Mitglied seit: 28.09.2007
Kommentare: 3'104
Info Termin Q4 bei CGC/WEED

Emil

Lorenz
Bild des Benutzers Lorenz
Offline
Zuletzt online: 09.11.2018
Mitglied seit: 16.04.2010
Kommentare: 1'405
Zahlen

Danke, ich werde hinschauen und ev. vielleicht, möglicherweise noch vorher...

Hier noch was von

ACB, da ist jemand ganz schön überzeugt, es geht auch in die richtige Richtung mit dem Kurs:

https://seekingalpha.com/article/4182564-cannabis-sales-start-soon-aurora-cannabis-play-need-know

 

 

Selector
Bild des Benutzers Selector
Offline
Zuletzt online: 31.10.2018
Mitglied seit: 06.06.2011
Kommentare: 678
Legalisierung / Cannabis ist durch

BiggrinDirol

Heute:

Dienstag, 19.06.2018 - 20:16 Uhr

Cannabis-Aktien gehen durch die Decke!

Heute machen die Cannabis-Aktien erneut einen kräftigen Sprung nach oben. Der Grund hierfür ist in Canada zu finden. Die Legalisierung von Cannabis ist durch! >

https://www.godmode-trader.de/analyse/cannabis-aktien-gehen-durch-die-decke,6157803

Quelle:

https://news.guidants.com/#!Ticker/Feed/?r=1

Emil
Bild des Benutzers Emil
Offline
Zuletzt online: 08.11.2018
Mitglied seit: 28.09.2007
Kommentare: 3'104
Spin out / Aurora Cannabis

Das kam heute noch durch die News (s. Link):

Aurora Cannabis to spin out U.S. assets into separate company

Canada's second largest cannabis company plans to place its U.S. assets into a new separate company that will focus on investing in the cannabis and real estate sector there.

Canadian shareholders will receive 1 share in new company for every 20 Aurora shares they own...

https://www.cbc.ca/news/business/aurora-cannabis-australis-capital-1.4713778

 

Emil

Emil
Bild des Benutzers Emil
Offline
Zuletzt online: 08.11.2018
Mitglied seit: 28.09.2007
Kommentare: 3'104
CGC-Zahlen

Nur noch zur Info, bin da nicht mehr drin, aber die Zahlen interessieren vermutlich.

https://www.cbc.ca/news/business/canopy-growth-earnings-1.4724145?cmp=rss

https://seekingalpha.com/news/3366550-canopy-growth-slips-5-percent-post-q4-results

Canopy Growth slips 5% post Q4 results

Jun. 27, 2018 10:10 AM ET|About: Canopy Growth Corporation (CGC)|By: , SA News Editor

Canopy Growth (CGC -5.2%) reports Q4 sales of C$22.8M, up 55% Y/Y attributable to launch of Spectrum Softgels, strong sales Canada, Germany, as well as expansion in Africa, Europe and Australia.

Sold 2,528 (+45%) kilograms and kilogram equivalent cannabinoids, at an average sales price of C$8.43 per gram (5%).

Adjusted EBITDA amounted to a loss of C$22.9M compared to loss of C$0.1M last year.

Cannabinoids harvested increased 143% to 4,811 kilograms.

Inventory stood at 15,726 kilograms of dry cannabis, 6,969 litres of cannabis oil and 356 kilograms of softgel capsules.

The company ended with C$323M in cash & cash equivalents.

Previously: Canopy Growth misses by $0.23, misses on revenue (June 27)

Click to subscribe to real-time analytics on CGC

 

 

Emil

Selector
Bild des Benutzers Selector
Offline
Zuletzt online: 31.10.2018
Mitglied seit: 06.06.2011
Kommentare: 678
ACB-News

@Emil

Danke für die Info oben.

 

Aurora (News von gestern):

Aurora Cannabis Announces $200 Million Debt Facility with BMO

Major Non-Dilutive Financing Deal with Canadian Tier 1 Bank Represents Significant Milestone in the Cannabis Sector

EDMONTON, June 26, 2018 - Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) announced today that it has agreed to a new $200 million debt facility, with a potential upsize to $250 million, with the Bank of Montreal ("BMO").

The facility will consist of a $150 million term loan and a $50 million revolving credit facility (together, the "Loans"), both of which will mature in 2021. A short period after the implementation of Bill C-45 in October 2018, the Company may request an increase of up to a further $45 million to the term loan subject to agreement by BMO and satisfaction of certain legal and business conditions. BMO will also be providing up to $5 million in other credit instruments. Closing of the debt facility is subject to completion of final due diligence, negotiation of definitive documentation, and satisfaction of conditions precedent customary to a financing of this nature.

The debt facility will be primarily secured by Aurora's production facilities, including Aurora Sky, Aurora Mountain, and Aurora Vie. Strategically located at Edmonton International Airport, Aurora Sky is the world's most technologically advanced cannabis facility, projected to produce in excess of 100,000 kg per year of high-quality cannabis at low per gram costs, and slated to deliver its first harvest this week.

"Having successfully met all of BMO's stringent risk assessment and other due diligence criteria to establish this facility reflects well on the maturity, progress and prospects of Aurora, as well as the quality and economic value of our production facilities," said Terry Booth, CEO. "This is by far the largest traditional debt facility in the cannabis industry to date. The funds provide us additional fuel to complement our end-to-end portfolio of vertically integrated, geographically and horizontally diversified assets, aimed at building a pre-eminent global cannabis company with a superior margin profile."

Glen Ibbott, CFO of Aurora, added, "The shift to traditional debt financing is significant.  Our cost of capital continues to decrease, providing us a distinct competitive advantage as we execute on our growth strategy. The non-dilutive nature and attractive pricing are consistent with Aurora's commitment to generating shareholder value. We believe this is a major milestone in the cannabis industry and a validation of our operational effectiveness. It also marks an exciting new stage of our long-term relationship with BMO, a Tier 1 bank with a sterling domestic and international reputation."

The Loans can be repaid without penalty at Aurora's discretion. The pricing of the Loans is a set margin over the BMO CAD Prime Rate or a Bankers' Acceptance of appropriate term. Based on the current BMO CAD Prime Rate, the interest payable is expected to be in the mid to high 4% per annum range over the term of the Loans.

More details on this new sector benchmark debt facility can be found in the Company's documents once filed on www.sedar.com.

 

News heute:

https://petitions.ourcommons.ca/en/Petition/Details?Petition=e-1528

Und Anfang diese Woch noch ein Video:

https://www.youtube.com/watch?v=hJgB-rgDuu4

 

Emil
Bild des Benutzers Emil
Offline
Zuletzt online: 08.11.2018
Mitglied seit: 28.09.2007
Kommentare: 3'104
Infos von ACB

Emil

petra129
Bild des Benutzers petra129
Offline
Zuletzt online: 18.11.2018
Mitglied seit: 10.11.2015
Kommentare: 115
Valuation Model On Public

Valuation Model On Public Traded Companies July 2018

 

image: http://i2.wp.com/palisade-research.com/wp-content/uploads/2018/07/g6.png...

 

Compared to their peers – Undervalued Marijuana Stocks by Rank.
1. GTEC.V
2. Hydropothecary
3. Organigram
4. Supreme
5. TGOD
6. Aphria

7-11 - overvalued. 

Read more at http://www.stockhouse.com/companies/bullboard#1rK8IitDKb965X6c.99

Selector
Bild des Benutzers Selector
Offline
Zuletzt online: 31.10.2018
Mitglied seit: 06.06.2011
Kommentare: 678
Info CGC / Termin für Zahlen

Canopy Growth Corporation to Announce First Quarter Fiscal 2019 Financial Results

August 1, 2018

 

SMITHS FALLS, ON—Canopy Growth Corporation (TSX:WEED, NYSE:CGC) (“Canopy Growth”) will release its financial results for the first quarter fiscal 2019 ended June 30, 2018 on August 14, 2018.

Contact:
Caitlin O’Hara
Media Relations
Caitlin.Ohara@canopygrowth.com
613-291-3239

Chrigu
Bild des Benutzers Chrigu
Offline
Zuletzt online: 18.11.2018
Mitglied seit: 13.01.2011
Kommentare: 870
Hat der Hipe bereits

Hat der Hipe bereits nachgelassen oder vorübergehendes Tief aufgrund Handelskrieg? Ich bin in WEEDTQ LEON C 04/21 investiert.

Nicht zu gierig werden vs. Hin und Her macht Taschen leer

Selector
Bild des Benutzers Selector
Offline
Zuletzt online: 31.10.2018
Mitglied seit: 06.06.2011
Kommentare: 678
CGC-Q1/2019 Ende Juni 2018
petra129
Bild des Benutzers petra129
Offline
Zuletzt online: 18.11.2018
Mitglied seit: 10.11.2015
Kommentare: 115
Canopy Jumps 47% in One Day –

Canopy Jumps 47% in One Day – Sets Stage for Next Huge Cannabis Rally

Posted on August 22, 2018 by Cannabis Stock Trader

The Cannabis sector just delivered its best day of the year after the third largest US beer brewer invested a record $3.8 billion in the largest cannabis company in the world.

Canopy Growth Corp (CGC), the largest cannabis company in the world, set the cannabis sector on fire last week after announcing a groundbreaking deal.

Constellation (STZ), the third largest US beer company and brewer of Corona, invested $3.8 billion into Canopy in the largest deal ever in the cannabis sector.

If my analysis is correct – the stage is now set for a huge rally in the second half of the year with two huge profit triggers directly on the horizon....

https://www.cannabisstocktrades.com/canopy-jumps-47-in-one-day-sets-stag...

petra129
Bild des Benutzers petra129
Offline
Zuletzt online: 18.11.2018
Mitglied seit: 10.11.2015
Kommentare: 115
CRON und mehr..

Canadian Marijuana Technical Analysis Chart 8/30/2018 by ChartGuys.com

https://www.youtube.com/watch?v=hoKeQrGs2ZA&app=desktop

petra129
Bild des Benutzers petra129
Offline
Zuletzt online: 18.11.2018
Mitglied seit: 10.11.2015
Kommentare: 115
Licensed producers of cannabis for medical purposes

 

Licensed producers of cannabis for medical purposes

 

A licence is required to produce or sell cannabis for medical purposes.

Licenced products include dried or fresh cannabis, cannabis oil, starting materials and plants.

People who are authorized by a health care professional can register to buy products from licenced producers. Learn more about accessing cannabis for medical purposes.

https://www.canada.ca/en/health-canada/services/drugs-medication/cannabi...

petra129
Bild des Benutzers petra129
Offline
Zuletzt online: 18.11.2018
Mitglied seit: 10.11.2015
Kommentare: 115
The Rapid Rise of a $22.6

The Rapid Rise of a $22.6 Billion
Canadian Industry

According to industry expert Deloitte, the Canadian marijuana industry could rapidly grow in size to become a CAD $22.6billion market over the coming years.ii

This “once-in-a-lifetime” legalization opportunity has sparked a wave of expansion plans among licensed producers.

For those investors looking to take advantage of the surge in value enjoyed by many Canadian marijuana companies, there have been some impressive returns, including…

  • Tilray, Inc. (TSE: TLRY) – up 202.94% over the past month and half…
    Canopy Growth (TSE: WEED) – up 406.9% over the past 12 months….
    Aurora Cannabis (TSE: ACB) – up 180.7% over the past 12 months…
    The Hydropothecary (TSE: HEXO) – up 210.1% over the past 12 months…

Those companies have seen large spikes in share their price due in large part to their anticipated production capacity.

But as the October 2018 legalization of recreational marijuana in Canada rapidly approaches, under-the-radar Maricann (CSE: MARI); (OTC: MRRCFremains undervalued by comparison…in spite of a number of distinct competitive advantages in both the medical and recreational sectors.

As legalization in Canada becomes a reality, production capacity and efficiency will become critical for licensed producers looking to thrive.

Emil
Bild des Benutzers Emil
Offline
Zuletzt online: 08.11.2018
Mitglied seit: 28.09.2007
Kommentare: 3'104
CGC (NY) WEED (Toronto)

Canopy Growth ist heute bereits wieder 10% gestiegen.

Ich bevorzuge nach wie vor Kanada, also Toronto, WEED.

Emil

petra129
Bild des Benutzers petra129
Offline
Zuletzt online: 18.11.2018
Mitglied seit: 10.11.2015
Kommentare: 115
Emil hat am 04.09.2018 18:00

Emil hat am 04.09.2018 18:00 geschrieben:

Canopy Growth ist heute bereits wieder 10% gestiegen.

Ich bevorzuge nach wie vor Kanada, also Toronto, WEED.

....da kann ich nur hoffen, dass Du früh rein bist und drin geblieben....hier mein mieses Beispiel: 5000 Canopy zu C$ 2.76 gekauft am 22.07.2016

verkauft zu C$ 4.07 am 10.08.2016 - und ich kam mir vor wie ein Krösus und war doch die dümmste Nuss, nie mehr rein aus weiss ich was für Gründen

könnte mir ohrfeigen...

 

brancusi-serrat
Bild des Benutzers brancusi-serrat
Offline
Zuletzt online: 26.09.2018
Mitglied seit: 11.06.2015
Kommentare: 82
der Aktionär heute
Selector
Bild des Benutzers Selector
Offline
Zuletzt online: 31.10.2018
Mitglied seit: 06.06.2011
Kommentare: 678
ACB Toronto

 

Ich bin nun da auch dabei, Aurora dürfte steigen. 

Grüsse von  fern zurzeit

 

Emil
Bild des Benutzers Emil
Offline
Zuletzt online: 08.11.2018
Mitglied seit: 28.09.2007
Kommentare: 3'104
ACB / Aurora

Ja, bin auch (wieder) drin. Habe gesehen, dass das Q4/2018 am 25.10.2018 gezeigt wird und das Q1/2019 am 29.10.2018, Highlights SmileDirol

Und dies ist noch vom Dienstag in dieser Woche, also vom 4.9.18:

 

Aurora Cannabis Closes $200 Million Debt Facility with BMO

Historic Financing with a Canadian Tier 1 Bank Provides Additional Capital to Drive Growth

EDMONTON, Sept. 4, 2018 - Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) today announced that it has closed its previously announced debt facility with the Bank of Montreal ("BMO"). The facility consists of a $150 million term loan and a $50 million revolving credit facility (together, the "Loans"), both of which mature in 2021. Included in the facility is an option to upsize the facility to $250 million total following the implementation of Bill C-45 on October 17, 2018, subject to agreement by BMO and satisfaction of certain legal and business conditions.

The debt facility is primarily secured by Aurora's production facilities, including Aurora Sky, Aurora Mountain, and Aurora Vie. Strategically located at Edmonton International Airport, Aurora Sky is the world's most technologically advanced cannabis facility, projected to produce in excess of 100,000 kg per year of high-quality, low-cost per gram, cannabis upon completion.

Management Commentary

"We are incredibly proud to have successfully closed this historic debt facility supported by a premier Canadian bank, BMO, who understands our needs and potential. This is both a reflection of the rapidly maturing nature of the broader cannabis industry and strong validation of the economic potential of Aurora's best-in-class, technologically advanced production facilities," said Terry Booth, CEO of Aurora. "With BMO and the syndicate lenders, Aurora gains significant runway to expansion opportunities that will positively contribute to our long-term margin profile and provide accelerated entry into multiple international markets. This additional capital positions us well to continue building the pre-eminent global cannabis company with a focus on vertically integrated, geographically and horizontally diversified assets."

Glen Ibbott, CFO of Aurora, added, "The closing conditions of this debt facility included stringent due diligence of Aurora's current production facilities as well as a thorough review of Aurora's projected revenue growth across all of our divisions. With our extremely strong balance sheet, Aurora is well positioned to execute on our business strategy, including accelerated development and launch of new products, continued rapid expansion of our domestic and international operations, and entry into new global markets."

Pursuant to the agreed upon conditions of the Loans, Aurora may, at its discretion, repay the balance of the Loans without penalty, at any time. The pricing of the Loans is a set margin over the BMO CAD Prime Rate or a Bankers' Acceptance of appropriate term. Based on the current BMO CAD Prime Rate, the interest payable is expected to be in the mid to high 4% per annum range over the term of the Loans. Additional details on this new sector benchmark debt facility can be found in the Company's documents that have been filed on www.sedar.com.

About Aurora 

Headquartered in Edmonton, Alberta, Canada with funded capacity in excess of 570,000 kg per year and sales and operations in 14 countries across five continents, Aurora is one of the world's largest and leading cannabis companies. Aurora is vertically integrated and horizontally diversified across every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis and hemp production, derivatives, high value-add product development, home cultivation, wholesale and retail distribution.

Highly differentiated from its peers, Aurora has established a uniquely advanced, consistent and efficient production strategy, based on purpose-built facilities that integrate leading-edge technologies across all processes, defined by extensive automation and customization, resulting in the massive scale production of high quality product at ultra-low costs. Intended to be replicable and scalable globally, these production facilities are designed to produce cannabis of significant scale, with high quality, industry-leading yields, and ultra-low per gram production costs. Each of Aurora's facilities is built to meet European Union (EU) GMP standards, and its first production facility, the recently acquired MedReleaf Markham facility, and its wholly owned European medical cannabis distributor Aurora Europe GmbH, have achieved this level of certification.

In addition to the Company's rapid organic growth and strong execution on strategic M&A, which to date includes 10 companies acquired – MedReleaf, CanvasRx, Peloton Pharmaceutical, Pedanios, H2 Biopharma, Urban Cultivator, BC Northern Lights, Larssen Greenhouses, CanniMed Therapeutics, and Anandia – Aurora is distinguished by its reputation as a partner of choice and employer of choice in the global cannabis sector, having invested in and established strategic partnerships with a range of leading innovators, including: The Green Organic Dutchman Holdings Ltd. (TSX: TGOD), Radient Technologies Inc. (TSXV: RTI), Hempco Food and Fiber Inc. (TSXV: HEMP), Cann Group Ltd. (ASX: CAN), Micron Waste Technologies Inc. (CSE: MWM), Choom Holdings Inc. (CSE: CHOO), Namaste Technologies Inc. (TSXV: N), Evio Beauty Group (private), Wagner Dimas (private), CTT Pharmaceuticals (OTCC: CTTH), Capcium Inc. (private), and Alcanna Inc. (TSX: CLIQ).

Aurora's Common Shares trade on the TSX under the symbol "ACB", and are a constituent of the S&P/TSX Composite Index.

For more information about Aurora, please visit our investor website, investor.auroramj.com, Twitter, Facebook or Instagram.

Terry Booth, CEO
Aurora Cannabis Inc.

Forward looking statements 

 

Emil

Ben
Bild des Benutzers Ben
Offline
Zuletzt online: 09.11.2018
Mitglied seit: 11.01.2010
Kommentare: 598
Aurora

https://www.stockwatch.com/News/Item.aspx?bid=Z-C%3aACB-2656788&symbol=ACB&region=C

Aurora erhält eine HealthCanada-Produktionslizenz für seine Aurora Eau Anlage in Lachute/Que. 

Aurora Cannabis Inc. hat für seine Aurora Eau-Anlage in Lachute, Que, eine Health Canada-Produktionslizenz erhalten. Das Unternehmen verfügt nun über sieben Produktionsstätten mit einer Produktionskapazität von über 160.000 Kilogramm pro Jahr. Aurora hat zusätzliche Anlagen in Entwicklung, so dass die gesamte finanzierte Kapazität auf mehr als 500.000 Kilogramm pro Jahr steigt. Darüber hinaus hat Aurora über seine hundertprozentige Tochtergesellschaft Medreleaf Corp. die Lizenz zur Herstellung von Öl für sein Werk in Bradford erhalten, das bei voller Kapazität eine Anbaufläche von 28.000 Kilogramm pro Jahr hat. Medreleaf Bradford verfügt über eine großvolumige Kohlendioxid-Extraktionsanlage, die die Ölproduktion erheblich steigern wird und in Erwartung des Erhalts der Verkaufslizenz erhebliche Mengen an Derivaten vorrätig hält. Aurora Eau, eine 48.000 Quadratfuß große Einrichtung mit einer Produktionskapazität von 4.500 Kilogramm pro Jahr, wurde speziell für die GMP-Standards (Good Manufacturing Practices) der Europäischen Union entwickelt und repräsentiert die nächste Entwicklung der Indoor-Grow-Anlagen von Aurora. Aurora Eau wurde gebaut, um Flexibilität in allen wichtigen Produktionsparametern zu ermöglichen, um die aktuellen exotischen Sorten des Unternehmens sowie neue Stämme, die noch nicht eingeführt wurden, und neue Genetik, die für den medizinischen Gebrauch und den Gebrauch für Erwachsene bestimmt sind, optimal anzupassen. Aurora Eau liegt in Lachute, Que., Und liegt auf einem 46 Hektar großen landwirtschaftlichen Nutzland, das Aurora für 136.000 Dollar für künftige Expansionszwecke erwerben kann. Dies würde die gewichtete Präsenz des Unternehmens in Quebec erweitern und zusätzliche Kapazitäten für die künftige Produktentwicklung und den Vertrieb bieten. Das Unternehmen wird sich wie auch seine anderen Einrichtungen im Rahmen der Verpflichtung des Unternehmens zum Aurora-Standard und zur weiteren Diversifizierung der Lieferkette auf dem Weg zu einer EU-GMP-Zertifizierung fortentwickeln. Bis heute hat Aurora zwei EU-GMP-Anbauanlagen in Kanada sowie eine EU-GMP-zertifizierte Einrichtung in Deutschland, die von ihrer hundertprozentigen Tochtergesellschaft Aurora Europe GmbH betrieben wird, für den Import, die Freisetzung und den Vertrieb von Cannabis. Der Anbau begann in Eau Der Anbau hat bei Aurora Eau begonnen, nachdem eine Mischung aus Klonen und ausgereiften Pflanzen mit einem maßgeschneiderten, umweltfreundlichen Transporter erhalten wurde, der von Auroras hundertprozentiger Tochter B.C. Nordlichter. Der neue Transporter ermöglicht es Aurora, große Mengen von Klonen und Müttern kostengünstig zu transportieren, was eine schnelle Ansiedlung neuer Einrichtungen ermöglicht. Nach dem erfolgreichen Transfer ist Aurora Eau jetzt in voller Produktion. Managementkommentar "Wir sind stolz auf die Errungenschaften von Aurora Eau und mit sieben Produktionslizenzen sind wir außerordentlich gut positioniert, um sowohl auf dem kanadischen als auch auf dem internationalen Markt weiter auf dem Markt zu bestehen", sagte Terry Booth, Chief Executive Officer von Aurora. "Mit der großtechnischen Produktion bei Aurora Sky haben wir die Möglichkeit, die Produktion von Aurora Eau in Nischenmärkten zu investieren, wodurch wir unsere Markenbekanntheit steigern und unser Margenprofil verbessern. Unsere neue Ölproduktionslizenz in Bradford erhöht unsere Produktionskapazität weiter höhermargige Öle und treiben Wachstum. "

 

Ben
Bild des Benutzers Ben
Offline
Zuletzt online: 09.11.2018
Mitglied seit: 11.01.2010
Kommentare: 598
AURORA
Lorenz
Bild des Benutzers Lorenz
Offline
Zuletzt online: 09.11.2018
Mitglied seit: 16.04.2010
Kommentare: 1'405
Aurora-Nes

von heute, spannend:

Aurora Cannabis acquires Agropro, Borela hemp outfits

2018-09-12 08:22 ET - News Release

 

Mr. Terry Booth reports

AURORA CANNABIS ACQUIRES EUROPE'S LARGEST ORGANIC HEMP COMPANY

Aurora Cannabis Inc. has acquired Europe's largest producer, processor and supplier of certified organic hemp and hemp products, Agropro UAB, as well as hemp processor and distributor Borela UAB.

Agropro, a hemp seed contracting and processing company, and its sister company Borela UAB, a processor and distributor of organic hulled hemp seeds, hemp seed protein, hemp flour and hemp seed oil, currently has 1,600 hectares (4,000 acres) under contract, potentially yielding more than one million kilograms of organic hemp with additional contracts available to expand to more than 3,000 hectares across Lithuania, Latvia, Estonia and Poland.

Previously, the companies were focused exclusively on the production and sale of hemp-seed-based products to markets across Europe, North America and Asia. Each year, very substantial quantities of CBD (cannabidiol) containing hemp biomass were left on the field unutilized.

Postacquisition, Aurora intends to extract, refine and productize the organic hemp biomass into a wide range of organic CBD-based wellness products to generate new and significant revenue streams in this burgeoning market. With increasing recognition of the medical and general health benefits of CBD-based products, Aurora continues executing on a CBD-focused strategy that covers the entire value chain, from supply, through genetics research and clinical trials, to product development and distribution to various domestic and international markets across five continents.

In addition to the CBD-related market potential, hemp is an increasingly sought-after food supplement and meat substitute for the large and rapidly growing health food, vegetarian and vegan markets, due to its high protein content. Through its majority-owned subsidiary Hempco, Aurora is already executing on a number of hemp food market opportunities, and intends to integrate Agropro's organic supply and distribution with Hempco's to enhance market access and accelerate growth of high-margin, premium hemp-based product offerings.

On Feb. 1, 2018, Borela's hemp grain processing facility became the only European hemp company to receive a BRC quality certificate, enabling Borela to supply supermarkets with its product. Borela's operations have also received USDA Organic, Eco-Cert, as well as other certifications, enabling the company to market premium products across large markets.

The organic certification achieved by both Agropro and Borela will enable the launch of new premium products, positively impacting the company's margin profile for hemp-based products.

Management commentary

"Agropro's position as Europe's leading producer of premium organic hemp along with the significant and previously unutilized CBD production from the large quantities of currently discarded biomass, makes this an accretive acquisition and one that positions Aurora well to become a global leader in organic CBD-based wellness products," said Terry Booth, chief executive officer.

Neil Belot, chief global business development officer, added: "With our industry-leading team of crop and plant scientists, extraction and product formulation expertise, and wide-reaching global distribution networks and partnerships, we anticipate increasing production, extraction, refinement and supply of CBD, as well as other hemp-based food products. With a broad European footprint, extensive contracted land agreements and solid existing revenue streams, Agropro and Borela provide further expansion of our international footprint, while playing an important role in the execution of our CBD wellness and hemp-based food products strategy."

Skirmantas Nikstele, co-founder and chief executive officer of Agropro, added: "As the largest producer, processor and supplier of organic hemp products in Europe, we have developed a strong reputation for quality and consistency with our customers across the globe. Through Aurora, we gain access to a wider distribution network, as well as an access to industry-leading science to help ramp up production, while enhancing margins through the introduction of new products, proven production techniques and robust genetics."

Hemp -- superfood with high market growth

The hemp plant is made up of three components. Seeds, which are used in food and personal care products, leaves and flowers, which produce cannabidiol (CBD), used in medical products, supplements and beauty products, and stalk, which produces fibre and hurd, used in paper products, building materials, clothing and other textiles.

Hemp seed oil offers the richest and most balanced source found in nature of essential fatty acids (EFAs), such as omega 3 and omega 6 oils. EFAs play a very important role in critically important processes, such as detoxification and the formation of brain cells, hormones and neurotransmitters. Hemp seed is not only rich in essential fatty acids, it also represents an important source for amino acids, which are the building blocks of protein. Essential amino acids are not produced by our bodies, and therefore must come from food. Hemp seeds contain all nine essential amino acids, as well as other nutritionally important vitamins and minerals, such as iron, zinc, carotene, vitamin B1, vitamin B2, vitamin B6, vitamin D, vitamin E, calcium, magnesium, potassium and enzymes.

These characteristics have resulted in strong continued market growth of hemp-based products. Grand View Research (industrial hemp market size, share and trends analysis, 2018) anticipates the industrial hemp market to grow at a compound annual growth rate of 14.0 per cent to $10.6-billion (U.S.) by 2025. The hemp seed market, as a subcategory, is anticipated to show even stronger growth.

With Agropro and Borela, Aurora has acquired a very substantial supply of organic hemp seed products, as well as the capacity to process the raw material into products, and the international distribution channels to sell these. Market reach will be further strengthened through integration with Hempco, while Aurora's science teams will be spearheading research into cultivation yield enhancements, as well as further medical and wellness applications.

Terms of the transaction

Aurora purchased 100 per cent of the issued and outstanding shares of Agropro UAB and Borela UAB for total cash consideration of 5,364,000 euros (approximately $8.1-million (Canadian)) and common shares of Aurora equivalent to 960,000 euros (approximately $1.4-million (Canadian)), based on the five-day volume-weighted average price as of Sept. 10, 2018. In addition, Aurora will also refinance existing debt totalling 2,076,000 euros (approximately $3.1-million (Canadian)) and provide a finder's fee totalling 1,517,400 euros (approximately $2.3-million (Canadian)).

About Aurora Cannabis Inc.

Headquartered in Edmonton, Alta., Canada, with financed capacity in excess of 570,000 kilograms per year and sales and operations in 14 countries across five continents, Aurora is one of the world's largest and leading cannabis companies. Aurora is vertically integrated and horizontally diversified across every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis and hemp production, derivatives, high value-add product development, home cultivation, and wholesale and retail distribution.

We seek Safe Harbor.

© 2018 Canjex Publishing Ltd. All rights reserved.

petra129
Bild des Benutzers petra129
Offline
Zuletzt online: 18.11.2018
Mitglied seit: 10.11.2015
Kommentare: 115
Canopy/SNB

SNB hat Canopy Aktien geposchtet - finde ich super!!!!

Selector
Bild des Benutzers Selector
Offline
Zuletzt online: 31.10.2018
Mitglied seit: 06.06.2011
Kommentare: 678
? WEED/CGC

@Petra

Hast du einen Link zur Info oder den Text. Es wäre nett, wenn wir das sehen könnten. Danke.

petra129
Bild des Benutzers petra129
Offline
Zuletzt online: 18.11.2018
Mitglied seit: 10.11.2015
Kommentare: 115
Selector hat am 13.09.2018 17

Selector hat am 13.09.2018 17:55 geschrieben:

@Petra

Hast du einen Link zur Info oder den Text. Es wäre nett, wenn wir das sehen könnten. Danke.

Nationalbank: Jetzt auch Big in Haschisch-Aktien

12.9.2018

Währungshüter kaufen alles auf, was ihnen in die Hände kommt – Neuerdings Gross-Aktionärin von „First Cannabis Company“....

https://insideparadeplatz.ch/2018/09/12/nationalbank-jetzt-auch-big-in-h...

.....ich nehme an es stimmt - sonst wäre sicher ein shitstorm losgebrochen.

Ben
Bild des Benutzers Ben
Offline
Zuletzt online: 09.11.2018
Mitglied seit: 11.01.2010
Kommentare: 598
CannabisAktien: Droht ärger aus den USA

Der Aktionär: http://www.deraktionaer.de/aktie/cannabis-aktien--canopy-growth--aurora-cannabis-und-co-brechen-ein---droht-aerger-aus-den-usa--397050.htm

Cannabis-Aktien: Canopy Growth, Aurora Cannabis und Co brechen ein – droht Ärger aus den USA?

Michel Doepke | Redakteur

14.09.2018 - 08:59 Uhr

AURORA CANNABIS5,40 € -2,70%CANOPY GROWTH38,90 € -1,44%TILRAY CL.294,70 € -6,45%

Cannabis zur medizinischen Verwendung

Die boomende kanadische Cannabis-Industrie scheint den USA ein Dorn im Auge zu sein. Wie das Magazin Politico berichtet, gibt es Überlegungen, gegen Pot-Investoren sowie -Arbeiter ein Einreiseverbot zu verhängen. Die Hintergründe für den Vorstoß liegen auf der Hand: Frisches Öl ins Handelsstreit-Feuer zwischen den USA und Kanada gießen.

Wie ein hochrangiger Beamter für Grenzkontrollen gegenüber Politicoverlauten ließ, könnten Marihuana-Raucher aus den USA verbannt werden. "Unsere Beamten werden nicht alle Einreisenden fragen, ob sie Marihuana konsumieren. Aber wenn Fragen in diese Richtung führen oder ein entsprechender Geruch aus dem Auto kommt, könnten wir eine Befragung durchführen", so Todd Owen.

Viel Rauch um wenig

Den USA geht es weniger um den Cannabis-Konsum an-sich. Eher geht es den Vereinigten Staaten darum, von der boomenden Industrie in Kanada überrollt zu werden. Schließlich wird dem Cannabis-Markt ein Multi-Milliarden-Potenzial nachgesagt. Zudem enstehen eine Vielzahl neuer Arbeitsplätze in der Branche.

Trotzdem sorgte der Bericht für stark fallende Notierungen bei den Cannabis-Aktien. Canopy Growth verlor im regulären Handel knapp 14 Prozent, Aurora Cannabis neun Prozent. Cronos, auf die sich die Shortseller von Citron Research eingeschossen haben, verlor ebenfalls gut zehn Prozent an Wert. Ein großer Pot-Stock konnte sich, zumindest im regulären Handel, mit einem satten Plus aus der Affäre ziehen: Tilray. Wie das Cannabis-Unternehmen gestern vorbörslich bekannt gab, werde man fortan Cannabisöl und -blüten nach Deutschland liefern. In der Spitze schoss das Papier auf 127,27 Dollar. Ein neues Rekordhoch. Nachbörslich verlor die Tilray-Aktie dann doch über fünf Prozent.

Nichts für schwache Nerven

Der Cannabis-Sektor ist in den vergangenen Wochen heiß gelaufen. Kein Wunder, dass die Cannabis-Aktien in der Folge mit satten Kursverlusten reagierten. Davon sollten sich investierte Anleger jedoch nicht verunsichern lassen. Fakt ist: Die Legalisierungswelle rollt, in Kanada wird es am 17. Oktober 2018 soweit sein. DER AKTIONÄR hat in der neuen Ausgabe die Branche genauer unter die Lupe genommen und erklärt in der Story, welche Aktien noch kaufenswert sind. Das ePaper steht Ihnen hier zum Download zur Verfügung.

Link
Bild des Benutzers Link
Offline
Zuletzt online: 02.11.2018
Mitglied seit: 20.12.2011
Kommentare: 4'201
GOLDSCHWÄCHE

GOLDSCHWÄCHE

Uhi, geht da bald CFM Konkurs?

 

Seiten